Incyte (INCY) Cash & Current Investments (2010 - 2026)

Incyte (INCY) reported Cash & Current Investments of $4.0 billion for Q1 2026, up 66.72% on a YoY basis from $2.4 billion in Q1 2025, and up 12.15% quarter-over-quarter from $3.6 billion in Q4 2025.

Incyte (INCY) Cash & Current Investments (2010 - 2026) Analysis & Trends

Incyte has reported Cash & Current Investments for 17 years, with the latest figure at $4.0 billion in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 66.72% year-over-year to $4.0 billion; the trailing twelve-month figure through Mar 2026 stood at $4.0 billion (up 66.72% YoY), and the FY2025 full-year result was $3.6 billion, up 65.92% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $4.0 billion, up from $3.6 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $4.0 billion in Q1 2026, with the low at $1.3 billion in Q3 2024.
  • Historically, Cash & Current Investments has averaged $2.9 billion across 5 years, with a median of $3.0 billion in 2022.
  • Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 62.82% — and 2025, when it soared 124.09%.
  • Incyte's Cash & Current Investments stood at $3.2 billion in 2022, then climbed by 12.88% to $3.7 billion in 2023, then plunged by 40.97% to $2.2 billion in 2024, then surged by 65.92% to $3.6 billion in 2025, then gained by 12.15% to $4.0 billion in 2026.
  • The last three Cash & Current Investments figures came in at $4.0 billion (Q1 2026), $3.6 billion (Q4 2025), and $2.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 4.02 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.02 Bn
Dec 31, 2025 3.58 Bn
Sep 30, 2025 2.93 Bn
Jun 30, 2025 2.42 Bn
Mar 31, 2025 2.41 Bn
Dec 31, 2024 2.16 Bn
Sep 30, 2024 1.31 Bn
Jun 30, 2024 1.45 Bn
Mar 31, 2024 3.85 Bn
Dec 31, 2023 3.66 Bn
Sep 30, 2023 3.52 Bn
Jun 30, 2023 3.42 Bn
Mar 31, 2023 3.11 Bn
Dec 31, 2022 3.24 Bn
Sep 30, 2022 2.98 Bn
Jun 30, 2022 2.72 Bn
Mar 31, 2022 2.54 Bn
Dec 31, 2021 2.35 Bn
Sep 30, 2021 2.28 Bn
Jun 30, 2021 2.08 Bn